CAH treatment may be linked to lower bone mineral density
Higher glucocorticoid doses for adults with CAH may be associated with lower bone mineral density, especially among women and those prescribed prednisolone, according to findings published in Clinical Endocrinology.
Recent Blog Posts
Webinar: Quality of life and fertility in CAH – 21st November 2026
The European Society for Endocrinology (ESE) is running a free webinar focussing on CAH on 21st November 2026. Hear from patients and clinicians from across Europe as the subjects of health-related quality of life and preserving fertility across the lifespan are...
Supporting Safer Adrenal Crisis Care
The Addison’s Disease Self-Help Group (ADSHG) has launched a national advocacy campaign to improve emergency treatment and patient safety for people at risk of adrenal crisis. The campaign was sparked by the discontinuation of liquid hydrocortisone in the UK, which...
Pituitary Awareness Month (October) – Symptoms in the Spotlight
October is Pituitary Awareness Month. Although not CAH, some of the information from the Pituitary Foundation may be helpful for those living with CAH. Find out more at the Pituitary Foundation's website here. Header image from Pituitary Foundation UK. Recent Blog...